# Lakefront Biotherapeutics NV: Form 6-K, filed Mar 6, 2026

- Company: [Lakefront Biotherapeutics NV](/companies/lkft.md) (CIK 1421876)
- Form: 6-K
- Filed: 2026-03-06
- Accepted by EDGAR: Mar 6, 2026, 16:28 ET
- Period: 2026-03-06
- Accession: 0001171843-26-001387
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1421876/000117184326001387/f6k_030626.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1421876/000117184326001387/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1421876/000117184326001387/f6k_030626.htm

Filed Mar 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-001387. Last ingested by Listed: Nov 12, 2026, 17:23 ET. No prices; not investment advice.